These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3376887)

  • 1. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
    Platia EV; Weisfeldt ML; Franz MR
    Am J Cardiol; 1988 Jun; 61(15):1284-7. PubMed ID: 3376887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
    Wyse DG; Mitchell LB; Duff HJ
    J Am Coll Cardiol; 1987 Apr; 9(4):882-9. PubMed ID: 3558987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of quinidine versus procainamide on the QT interval.
    Reiter MJ; Higgins SL; Payne AG; Mann DE
    Am J Cardiol; 1986 Sep; 58(6):512-6. PubMed ID: 3751914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
    Vereckei A; Warman E; Mehra R; Zipes DP
    J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
    Lee SD; Newman D; Ham M; Dorian P
    J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinidine pharmacodynamics in patients with arrhythmia: effects of left ventricular function.
    Gillis AM; Mitchell LB; Wyse DG; McDonald M; Duff HJ
    J Am Coll Cardiol; 1995 Apr; 25(5):989-94. PubMed ID: 7897143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK
    Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
    Kus T; Costi P; Dubuc M; Shenasa M
    Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome.
    Shimizu W; Ohe T; Kurita T; Takaki H; Aihara N; Kamakura S; Matsuhisa M; Shimomura K
    Circulation; 1991 Nov; 84(5):1915-23. PubMed ID: 1657447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial uptake and pharmacodynamics of procainamide in patients with coronary heart disease and sustained ventricular tachyarrhythmias.
    Gillis AM; Duff HJ; Mitchell LB; Wyse DG
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1001-6. PubMed ID: 8355178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
    Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.